Learn more

HABASH LOUIS

Overview
  • Total Patents
    24
  • GoodIP Patent Rank
    87,241
  • Filing trend
    ⇩ 75.0%
About

HABASH LOUIS has a total of 24 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AMARIN NEUROSCIENCE LTD, BULLERDIEK JOERN and OXO CHEMIE AG.

Patent filings in countries

World map showing HABASH LOUISs patent filings in countries

Patent filings per year

Chart showing HABASH LOUISs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Habash Louis 24
#2 Jones Clarence 5

Latest patents

Publication Filing date Title
US2019224179A1 Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxide
US2019224178A1 Altering expression level of glutathione S-transferase genes by treating a human subject with a nitroxide
US2018078539A1 T-cell regulation in t-cell mediated diseases by reducing pathogenic function of th17 in a human subject through treatment with a nitroxide
US2018078538A1 Method of treating a human subject having a desmosome associated disorder by administering a nitroxide
US2018092891A1 Preventing amyloid plaque formation by treating a human subject with a nitroxide
WO2017200953A1 Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
CA3056059A1 Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US2017326122A1 Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US9700550B1 Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US2017273958A1 Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US9744162B1 Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US9579311B1 Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US9545398B1 Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US2009209581A1 Nitroxides for use in treating or preventing immunological diseases
US2009042937A1 Nitroxides for use in treating or preventing amyloid-related diseases
US2008319014A1 Nitroxides for use in treating predisposed or at risk patients
US2012046314A1 Nitroxides for use in treating or preventing neoplastic disease
US2009062338A1 Nitroxides for use in treating or preventing cardiovascular disease